NewsMar | 10 | 2022
Yes. The CDC has stated that people with cancer may receive the COVID-19 vaccines, as long as they have had no issues with getting vaccines in the past.
If your current treatment includes chemotherapy, immunotherapy, targeted therapies, or radiation therapy, you should talk with your care team in deciding when to get vaccinated.
In making your decision, you should consider your risk of exposure to the virus, what your chances of getting very sick might be if you do get the virus, and when you will finish treatment.
If you are done with treatment, you should get vaccinated. This includes patients who are still being seen as part of post-treatment or are thought of as being in the “survivorship” part of their journey.
No. At this time, there is no evidence to suggest that the vaccines will affect your cancer treatment.
Vaccine Availability and Scheduling
For more information and FAQs about the COVID-19 vaccines, please visit this page.
Latest COVID-19 Vaccine Updates
Vaccines against SARS-CoV-2, the virus that causes COVID-19 infection, are safe in people undergoing treatment for cancer. The vaccines produced modestly impaired immune responses in patients with cancer, but booster vaccine doses enhanced immunity.
View recommendations for receiving the COVID-19 vaccine after cancer surgery requiring lymph node removal under the arm.
Please view Mass General's updated visitor policy.
View COVID-19 Information for Cancer Center Patients, including FAQs.
The Mass General Cancer Center is ready, willing, and able to see patients. Patients may have some anxiety about coming to the hospital because of the pandemic, but ease some of those concerns by hearing how we are keeping patients and staff safe.
Virtual healthcare visits have quickly become the norm. Dr. Steven Isakoff, Breast Oncologist, provides tips for making your Mass General Cancer Center virtual visit run smoothly.
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
